GP 118 (Mefloquine 250 mg)
Pill imprint GP 118 has been identified as Mefloquine hydrochloride 250 mg.
Mefloquine is used in the treatment of malaria prevention; malaria and belongs to the drug class antimalarial quinolines. There is no proven risk in humans during pregnancy. Mefloquine 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- GP 118
- Strength:
- 250 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Antimalarial quinolines
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00781-5076
- Inactive Ingredients:
- microcrystalline cellulose
crospovidone
low substituted hydroxypropyl cellulose
lactose monohydrate
magnesium stearate
corn starch
magnesium silicate
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54569-5407 | A-S Medication Solutions, LLC (repackager) |
| 54868-5434 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
More about mefloquine
Consumer resources
- Other brands: Lariam
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
